Approvals/TGA/BUVIDAL WEEKLY buprenorphine 16 mg/0.32 mL modified release solution for injection

Approved

STANDARD

BUVIDAL WEEKLY buprenorphine 16 mg/0.32 mL modified release solution for injection

Camurus Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 262beb66073f030e
Product Name: BUVIDAL WEEKLY buprenorphine 16 mg/0.32 mL modified release solution for injection
Artg Id: 295010
Artg Name: BUVIDAL WEEKLY buprenorphine 16 mg/0.32 mL modified release solution for injection
Sponsor: Camurus Pty Ltd
Company Detail Path: /organization/camurus-pty-ltd
Artg Date: 2018-11-28
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/a2e4365907a1b8ef072ff080ddd7fef6.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/8b2a7f3c41e7cdc66dcdeab7420aae51.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

262beb66073f030e

Type

Standard